IHS Chemical Week

Bayer to acquire German pharmaceutical company

11:43 AM MDT | May 17, 2013

Bayer says it has signed an agreement to acquire all of the shares of Steigerwald Arzneimittelwerk (Darmstadt, Germany), a privately held pharmaceutical company specializing in pharmacy-only herbal medicines. Financial details of the deal have not been disclosed. Steigerwald’s product portfolio includes Iberogast for the treatment of functional gastrointestinal disorders and Laif for the treatment of mild to moderate depression. The transaction is expected to close in July. Steigerwald generated sales of €61.3 million ($79 million) in 2012. The company...

Access is for Chemweek 24/7 PLUS Members ONLY

This information is only available to Chemweek 24/7 PLUS members who have subscribed to Chemweek’s Business Daily. If you are a member, please log in, OR if you have a trial membership, please use your trial membership account information. 

Username:
Password:

Forgot your user ID or password? Click here to have it sent to you.

 

 

If you are not yet a subscriber and would like to access the turnkey information found only in Chemweek’s Business Daily, subscribe now and you’ll get the most important news of the chemical industry delivered directly to your inbox—every day.

Sign up for a FREE 15-day trial of IHS Chemical Week Business Daily













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa